Polyrizon (PLRZ) Competitors $1.07 +0.27 (+33.75%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock PLRZ vs. SNYR, JATT, ELEV, CING, DRRX, LGVN, LPCN, COCP, MRKR, and GOVXShould you be buying Polyrizon stock or one of its competitors? The main competitors of Polyrizon include Synergy CHC Corp. (Uplisting) (SNYR), JATT Acquisition (JATT), Elevation Oncology (ELEV), Cingulate (CING), DURECT (DRRX), Longeveron (LGVN), Lipocine (LPCN), Cocrystal Pharma (COCP), Marker Therapeutics (MRKR), and GeoVax Labs (GOVX). These companies are all part of the "pharmaceutical products" industry. Polyrizon vs. Its Competitors Synergy CHC Corp. (Uplisting) JATT Acquisition Elevation Oncology Cingulate DURECT Longeveron Lipocine Cocrystal Pharma Marker Therapeutics GeoVax Labs Polyrizon (NASDAQ:PLRZ) and Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, community ranking, institutional ownership, profitability and media sentiment. Do analysts prefer PLRZ or SNYR? Synergy CHC Corp. (Uplisting) has a consensus target price of $10.00, suggesting a potential upside of 336.68%. Given Synergy CHC Corp. (Uplisting)'s stronger consensus rating and higher possible upside, analysts clearly believe Synergy CHC Corp. (Uplisting) is more favorable than Polyrizon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Polyrizon 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Synergy CHC Corp. (Uplisting) 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Does the media refer more to PLRZ or SNYR? In the previous week, Synergy CHC Corp. (Uplisting) had 7 more articles in the media than Polyrizon. MarketBeat recorded 9 mentions for Synergy CHC Corp. (Uplisting) and 2 mentions for Polyrizon. Polyrizon's average media sentiment score of 1.87 beat Synergy CHC Corp. (Uplisting)'s score of 0.94 indicating that Polyrizon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Polyrizon 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Synergy CHC Corp. (Uplisting) 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is PLRZ or SNYR more profitable? Company Net Margins Return on Equity Return on Assets PolyrizonN/A N/A N/A Synergy CHC Corp. (Uplisting) N/A N/A N/A Which has higher valuation & earnings, PLRZ or SNYR? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolyrizonN/AN/AN/AN/AN/ASynergy CHC Corp. (Uplisting)$33.59M0.63N/AN/AN/A Does the MarketBeat Community prefer PLRZ or SNYR? Synergy CHC Corp. (Uplisting) received 2 more outperform votes than Polyrizon when rated by MarketBeat users. Likewise, 66.67% of users gave Synergy CHC Corp. (Uplisting) an outperform vote while only 0.00% of users gave Polyrizon an outperform vote. CompanyUnderperformOutperformPolyrizonOutperform VotesNo VotesUnderperform Votes2100.00% Synergy CHC Corp. (Uplisting)Outperform Votes266.67% Underperform Votes133.33% SummarySynergy CHC Corp. (Uplisting) beats Polyrizon on 8 of the 9 factors compared between the two stocks. Get Polyrizon News Delivered to You Automatically Sign up to receive the latest news and ratings for PLRZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PLRZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLRZ vs. The Competition Export to ExcelMetricPolyrizonPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.70M$6.92B$5.61B$8.62BDividend YieldN/A2.55%5.28%4.17%P/E RatioN/A8.6727.1419.96Price / SalesN/A262.53411.83157.63Price / CashN/A65.8538.2534.64Price / BookN/A6.597.064.69Net IncomeN/A$143.75M$3.23B$248.14M7 Day Performance26.42%3.72%2.67%2.39%1 Month Performance-98.78%11.01%8.82%6.05%1 Year PerformanceN/A3.87%31.44%13.60% Polyrizon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLRZPolyrizonN/A$1.07+33.8%N/AN/A$5.70MN/A0.00N/ANews CoveragePositive NewsGap UpHigh Trading VolumeSNYRSynergy CHC Corp. (Uplisting)3.825 of 5 stars$2.04-1.4%$10.00+390.2%N/A$18.76M$33.59M0.0040News CoverageJATTJATT AcquisitionN/A$1.07+5.9%N/A-66.0%$18.46MN/A0.003High Trading VolumeELEVElevation Oncology3.4049 of 5 stars$0.30-0.2%$3.39+1,013.0%-88.9%$18.02MN/A-0.3740Trending NewsAnalyst DowngradeShort Interest ↓Analyst RevisionCINGCingulate1.9721 of 5 stars$4.24+6.5%$26.00+513.2%+552.1%$18.00MN/A-0.5020Short Interest ↑Gap DownDRRXDURECT1.3768 of 5 stars$0.58+1.0%N/A-58.6%$17.94M$1.86M-0.9580Positive NewsLGVNLongeveron3.5364 of 5 stars$1.19+0.8%$8.67+628.3%+65.9%$17.62M$2.23M-0.1920News CoverageGap DownLPCNLipocine2.3318 of 5 stars$3.20flat$9.00+181.3%-57.8%$17.12M$3.67M-4.2110Analyst ForecastAnalyst RevisionCOCPCocrystal Pharma2.6463 of 5 stars$1.65-1.8%$7.00+324.1%-39.7%$17.09MN/A-0.8910Short Interest ↑MRKRMarker Therapeutics4.2978 of 5 stars$1.51-0.7%$13.17+772.0%-51.6%$17.09M$6.59M-1.1460Positive NewsGOVXGeoVax Labs3.4559 of 5 stars$1.12+6.7%$11.10+891.1%-26.5%$17.02M$5.59M-0.3110News Coverage Related Companies and Tools Related Companies Synergy CHC Corp. (Uplisting) Alternatives JATT Acquisition Alternatives Elevation Oncology Alternatives Cingulate Alternatives DURECT Alternatives Longeveron Alternatives Lipocine Alternatives Cocrystal Pharma Alternatives Marker Therapeutics Alternatives GeoVax Labs Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLRZ) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polyrizon Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Polyrizon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.